Anti-FGF9/GAF antibody [EPR19937]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(11 Publications)
Rabbit Recombinant Monoclonal FGF9/GAF antibody. Suitable for WB and reacts with Recombinant full length protein - Human, Mouse, Rat, Human samples. Cited in 11 publications.
View Alternative Names
Fibroblast growth factor 9, FGF-9, Glia-activating factor, Heparin-binding growth factor 9, GAF, HBGF-9, FGF9
- WB
Supplier Data
Western blot - Anti-FGF9/GAF antibody [EPR19937] (AB206408)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1-3 : 15 seconds; Lane 4 : 3 minutes.
The MW observed is consistent with the literature (PMID : 16452189, PMID : 25925261).
All lanes:
Western blot - Anti-FGF9/GAF antibody [EPR19937] (ab206408) at 1/1000 dilution
Lane 1:
C6 (Rat glial tumor cell line) whole cell lysate at 10 µg
Lane 2:
PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg
Lane 3:
NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Lane 4:
U-87 MG (Human glioblastoma-astrocytoma epithelial cell line) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 26 kDa
false
- WB
Supplier Data
Western blot - Anti-FGF9/GAF antibody [EPR19937] (AB206408)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1/2 : 15 seconds; Lane 3 : 30 seconds.
The MW observed is consistent with the literature (PMID : 16452189, PMID : 25925261).
All lanes:
Western blot - Anti-FGF9/GAF antibody [EPR19937] (ab206408) at 1/1000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal kidney lysate at 10 µg
Lane 3:
Human ovary cancer lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 26 kDa
false
- WB
Unknown
Western blot - Anti-FGF9/GAF antibody [EPR19937] (AB206408)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1/2 : 1 seconds; Lane 3 : 15 seconds.
Human FGF9/GAF active protein contains aa1-208; FGF16 and FGF20 recombinant protein contain aa1-203 and aa4-208 respectively, both with His-Tag®.
All lanes:
Western blot - Anti-FGF9/GAF antibody [EPR19937] (ab206408) at 1/1000 dilution
Lane 1:
Human FGF9/GAF active protein at 0.01 µg
Lane 2:
Human FGF16 recombinant protein at 0.01 µg
Lane 3:
Human FGF20 recombinant protein at 0.01 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Supplier Data
Western blot - Anti-FGF9/GAF antibody [EPR19937] (AB206408)
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure times : Lane 1/2 : 15 seconds; Lane 3 : 30 seconds.
The MW observed is consistent with the literature (PMID : 16452189, PMID : 25925261).
All lanes:
Western blot - Anti-FGF9/GAF antibody [EPR19937] (ab206408) at 1/1000 dilution
Lane 1:
Mouse kidney lysate at 10 µg
Lane 2:
Mouse brain lysate at 10 µg
Lane 3:
Rat brain lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 23 kDa
Observed band size: 26 kDa
false
Related conjugates and formulations (1)
-
Anti-FGF9/GAF antibody [EPR19937] - BSA and Azide free (Detector)
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FGF9 contributes to important processes in the development and maintenance of several tissues. It is not known to be part of a larger complex. FGF9 regulates cellular activities such as proliferation and differentiation through its interaction with specific receptors on the cell surface. Its role is significant in skeletal and nervous system development where it ensures proper maturation and function of these systems.
Pathways
The FGF9 protein participates in the MAPK/ERK and PI3K/AKT signaling pathways. These pathways are important for cell survival proliferation and differentiation. FGF9 interacts closely with other fibroblast growth factors such as FGF2 to ensure effective signaling cascades. These interactions affect various cellular responses and contribute to the normal development of multiple organ systems.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (11)
Recent publications for all applications. Explore the full list and refine your search
NPJ biofilms and microbiomes 10:142 PubMed39627243
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cardiothoracic surgery 19:314 PubMed38824534
2024
Applications
Unspecified application
Species
Unspecified reactive species
Analytical cellular pathology (Amsterdam) 2023:5911546 PubMed37035017
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 12: PubMed36358989
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:850128 PubMed35517790
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 23:131 PubMed34970354
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 13:13674-13682 PubMed35035706
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34490480
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 12:344 PubMed34112245
2021
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 100:e23423 PubMed33545926
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com